• Contralateral Brain-to-Spinal Circuits Shape Mechanical Allo

  2026-04-21

  This study reveals a specific brain-to-spinal circuit that controls the laterality and duration of mechanical allodynia (MA) in mice. By dissecting the neural pathways and modulatory systems underlying MA, the research provides new mechanistic insight into chronic pain regulation and highlights potential targets for future therapeutic strategies.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Guide

  2026-04-20

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides sensitive, specific detection of goat IgG in immunofluorescence, IHC, flow cytometry, and ELISA workflows where fluorescent signal amplification is required. It is not suitable for assays using non-goat primary antibodies or for applications demanding cross-species reactivity.

• Fucoidan Downregulates Caveolin-1 in MCF-7 Breast Cancer Cel

  2026-04-20

  The referenced study demonstrates that fucoidan, a marine-derived sulfated polysaccharide, significantly downregulates caveolin-1 expression in MCF-7 breast cancer cells, reducing proliferation, migration, and colony formation. This evidence positions caveolin-1 as a novel target in breast cancer and highlights the mechanistic distinctiveness of natural compounds compared to standard agents such as tamoxifen.

• AT13387: Workflow-Driven Hsp90 Inhibitor Strategies in Cance

  2026-04-19

  AT13387 is a next-generation, orally bioavailable Hsp90 inhibitor with nanomolar potency and tumor-specific retention, uniquely enabling robust apoptosis and cell cycle arrest studies. This guide delivers actionable protocol enhancements, troubleshooting insights, and real-world use-case differentiation for advanced cancer biology research.

• MLN4924 and the Neddylation Axis: Catalyzing Translational B

  2026-04-18

  This article provides a thought-leadership perspective on MLN4924, a selective NEDD8-activating enzyme inhibitor, highlighting mechanistic insights, experimental strategies, and translational opportunities in cancer biology research. It integrates recent advances in ribotoxic stress signaling and neddylation pathway inhibition, offering actionable guidance for researchers aiming to leverage targeted protein degradation for anti-cancer therapy.

• Dacarbazine: Mechanistic Insights to Translational Impact

  2026-04-17

  This article provides scientific and strategic guidance for translational researchers leveraging Dacarbazine, an antineoplastic chemotherapy drug, with a deep dive into its DNA alkylation mechanism, experimental validation, clinical utility, and emerging best practices. Integrating recent findings and workflow recommendations, it highlights opportunities for innovation in cancer DNA damage pathway research and offers a forward-looking perspective rooted in evidence.

• Pazopanib (GW-786034): Targeting Angiogenesis in ATRX-Defici

  2026-04-16

  Explore the mechanistic power and translational promise of Pazopanib (GW-786034) in cancer research, with a special focus on ATRX-deficient high-grade gliomas. This article bridges molecular insight with practical guidance for translational workflows, uniquely positioning APExBIO’s Pazopanib as a tool for next-generation angiogenesis inhibition.

• Recent Synthetic Advances in (S)-(+)-Ibuprofen and NSAID Res

  2026-04-15

  This review outlines recent innovations in the synthesis of ibuprofen and naproxen, emphasizing improvements in efficiency, selectivity, and sustainability. The findings highlight how contemporary synthetic methods address both practical pharmaceutical production and the need for potent, selective COX inhibitors in advanced inflammation pathway research.

• Toremifene’s Role in Breast Cancer Therapy: 20 Years Reviewe

  2026-04-14

  This review synthesizes two decades of clinical data on toremifene, a selective estrogen receptor modulator, in breast cancer therapy. It highlights the evolution of biomarker-driven treatments, the pharmacologic nuances distinguishing toremifene from tamoxifen, and clinical implications for postmenopausal patient management.

• Dual-Action Stent Suppresses Tracheal Restenosis via Anti-In

  2026-04-13

  Zhao et al. developed an airway stent integrating anti-inflammatory and anti-angiogenic properties to address tracheal in-stent restenosis (TISR), a persistent complication in airway interventions. Their approach demonstrates effective suppression of inflammation, angiogenesis, and fibroblast activation in preclinical models, providing a foundation for next-generation stent design.

• Baicalin Methyl Ester Restores Intestinal Barrier via P65/TN

  2026-04-12

  This study demonstrates that baicalin methyl ester (BME) mitigates LPS-induced intestinal barrier damage in mice and MODE-K cells by modulating the P65/TNF-α/MLCK/ZO-1 signaling axis. The findings highlight BME’s capacity to restore tight junction integrity and downregulate pro-inflammatory mediators, offering mechanistic insight into intestinal inflammation management.

• Structure-Based Discovery of NSP15 Inhibitors for SARS-CoV-2

  2026-04-12

  This study employs structure-based virtual screening to identify thymopentin and oleuropein as potent inhibitors of the SARS-CoV-2 NSP15 endoribonuclease. The findings highlight the potential for repurposing natural products to target viral immune evasion mechanisms, offering new directions for COVID-19 therapeutic research.

• Bromodomain Inhibitor, (+)-JQ1: Advanced BET Inhibition Work

  2026-04-11

  Discover how Bromodomain Inhibitor, (+)-JQ1 from APExBIO empowers translational research across cancer, inflammation, and reproductive biology. Leverage precise experimental design, troubleshooting strategies, and evidence-driven protocol parameters to maximize assay reliability and biological insight.

• Oligomycin A: Mitochondrial ATP Synthase Inhibitor in Action

  2026-04-11

  Oligomycin A stands out as a precision tool for dissecting mitochondrial energy metabolism and apoptosis pathways, enabling high-fidelity studies in cancer metabolism research and beyond. This article unpacks advanced workflows, troubleshooting strategies, and protocol enhancements that maximize the impact of Oligomycin A in mitochondrial bioenergetics research.

• Tacalcitol Monohydrate: Molecular Innovations in Cancer a...

  2026-04-10

  Explore the advanced molecular mechanisms of Tacalcitol monohydrate, a synthetic analog of vitamin D3, as a vitamin D receptor agonist in cancer and dermatology research. Discover unique insights into gene regulation, anticancer synergy, and neuroregenerative potential not covered in other articles.

408 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page